Your browser doesn't support javascript.
loading
Clinical intervention effect of Xuefu Zhuyu decoction on chronic heart failure complicated with depression.
Wang, Ying; Wang, Jun; Lv, Wang; Chen, Hu; Yang, Qian; Zhang, Yang; Guo, Run; Ma, Xiao-Li; Zhang, Qian-Yu.
Afiliação
  • Wang Y; Department of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China. wangying_30@126.com.
  • Wang J; Department of Cardiology, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Lv W; Department of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Chen H; Department of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Yang Q; Department of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Zhang Y; Department of Traditional Chinese Medicine, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Guo R; Department of Cardiology, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Ma XL; Department of Cardiology, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
  • Zhang QY; Department of Cardiology, Cangzhou Central Hospital, Cangzhou 061000, Hebei Province, China.
World J Psychiatry ; 14(6): 857-865, 2024 Jun 19.
Article em En | MEDLINE | ID: mdl-38984345
ABSTRACT

BACKGROUND:

The diagnosis and treatment of depression in patients with chronic heart failure (CHF) is challenging, with no ideal treatment at present.

AIM:

To analyze the clinical intervention effect of Xuefu Zhuyu decoction (XFZYD) on CHF complicated with depression.

METHODS:

The study cohort comprised 116 patients with CHF complicated with depression who received treatment from July 2020 to July 2023, of which 55 received Western medicine (control group) and 61 received XFZYD (research group). Data on clinical effectiveness, traditional Chinese medicine (TCM) syndrome score, cardiac function, negative emotions, and serum inflammatory factors, were collected for comparative analyses.

RESULTS:

Compared with the control group, the research group had an evidently higher total effective rate. Furthermore, there were marked reductions in TCM symptom score, left ventricular end-diastolic diameter, left ventricular end-systolic diameter, Self-Rating Depression Scale, Hamilton Depression Scale, high-sensitivity C-reactive protein, monocyte chemoattractant protein-1, and matrix metalloproteinase-9 in the research group after treatment, and these were lower than the corresponding values in the control group. Left ventricular ejection fraction was increased and higher in the research group compared with the control group after treatment.

CONCLUSION:

Our findings conclusively proved that XFZYD was considerably superior to Western medicine for treating CHF complicated with depression because it significantly alleviated patients' symptoms, improved cardiac function, relieved negative emotions, and reduced the levels of serum inflammatory factors.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article